SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-139969
Filing Date
2017-04-27
Accepted
2017-04-26 18:55:01
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1/A d128073ds1a.htm S-1/A 1840737
2 EX-23.1 d128073dex231.htm EX-23.1 1397
3 GRAPHIC g128073g13r76.jpg GRAPHIC 102281
4 GRAPHIC g128073g14q30.jpg GRAPHIC 113128
5 GRAPHIC g128073g22x07.jpg GRAPHIC 52260
6 GRAPHIC g128073g25w29.jpg GRAPHIC 188235
7 GRAPHIC g128073g33j28.jpg GRAPHIC 69258
8 GRAPHIC g128073g41f58.jpg GRAPHIC 129859
9 GRAPHIC g128073g51r42.jpg GRAPHIC 102323
10 GRAPHIC g128073g52f64.jpg GRAPHIC 202194
11 GRAPHIC g128073g54r07.jpg GRAPHIC 125059
12 GRAPHIC g128073g61s41.jpg GRAPHIC 85597
13 GRAPHIC g128073g77n82.jpg GRAPHIC 48506
14 GRAPHIC g128073g86a11.jpg GRAPHIC 79856
15 GRAPHIC g128073g96x32.jpg GRAPHIC 143183
  Complete submission text file 0001193125-17-139969.txt   3807426
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-217285 | Film No.: 17785758
SIC: 2834 Pharmaceutical Preparations